Hidenobu Arimura

Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and aclarubicin for previously treated acute myelogenous leukemia: a pilot study.

Koki Yamada, S Furusawa, Kei Saito et al. · PubMed · 1995 · 106 citations

Medicine, Hematology, Oncology +16

<i>SET binding factor 2 (SBF2)</i> mutation causes CMT4B with juvenile onset glaucoma

Ryuki Hirano, Hiroshi Takashima, Fujio Umehara et al. · Neurology · 2004 · 42 citations

Life Sciences, Genetics, Molecular Genetics +17

Hereditary motor and sensory neuropathy with myelin folding and juvenile onset glaucoma

Takashiro Kiwaki, Fujio Umehara, Hiroshi Takashima et al. · Neurology · 2000 · 20 citations

Life Sciences, Genetics, Neurology +17

Risk factors for disease progression in Japanese patients with COVID-19 with no or mild symptoms on admission

Toshifumi Ninomiya, Kohei Otsubo, Teppei Hoshino et al. · BMC Infectious Diseases · 2021 · 13 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +5

Remarkable response to dacomitinib in a patient with leptomeningeal carcinomatosis due to <scp><i>EGFR</i></scp>‐mutant non‐small cell lung cancer

Shun Mizusaki, Kohei Otsubo, Toshifumi Ninomiya et al. · Thoracic Cancer · 2020 · 10 citations · Full text

Medicine, Neurology, Oncology +17